SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001005201-19-000099
Filing Date
2019-08-14
Accepted
2019-08-14 16:33:22
Documents
1
Period of Report
2019-08-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_156581477995235.html 4  
1 FORM 4 wf-form4_156581477995235.xml 4 3104
  Complete submission text file 0001005201-19-000099.txt   4611
Mailing Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045
Business Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Therapeutics, Inc (Issuer) CIK: 0001005201 (see all company filings)

IRS No.: 943229046 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O OCERA THERAPEUTICS 525 UNIVERSITY AVENUE, SUITE 610 PALO ALTO CA 94301
Business Address
Bukofzer Stan (Reporting) CIK: 0001663041 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-13111 | Film No.: 191026993